Insulet Corporation (GOV)
FSX
Real-time Data
06:00 AM
Day's Range
124.5552 wk Range
112.45Overview - GOV - Insulet Corporation
Key Statistics
Valuation
Enterprise Value
7.88B
P/E (Trailing)
‪27.75‬
P/E (Forward)
‪81.83‬
PEG Ratio
‪0.08‬
Price / Sales (TTM)
‪2.88‬
Price / Book
‪7.22‬
EV / EBITDA
‪14.98‬
Profitability
Gross Margin
‪70.17%‬
Profit Margin
‪12.29%‬
Operating Margin
‪16.17%‬
Return on Assets
‪9.71%‬
Return on Equity
‪26.01%‬
Ownership
Shares Outstanding
69.35M
Float
69.06M
Held by Insiders
‪0.32%‬
Held by Institutions
‪107.08%‬
Price stats
Beta
‪1.09‬
50-Day Avg
‪134.26‬
200-Day Avg
‪183.94‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - GOV - Insulet Corporation
Peers - GOV - Insulet Corporation
Peer Comparison
Compared with companies in Medical Devices listed on FSX.
Profile Summary - GOV - Insulet Corporation
About
Insulet Corporation is a medical device company specializing in insulin delivery technologies for people living with insulin‑dependent diabetes. The company focuses on its Omnipod platform, a family of tubeless, wearable, pod-based insulin management systems designed to provide continuous subcutaneous insulin infusion…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
